Tom Russo's ABT Position Overview
Tom Russo (via Gardner Russo & Quinn LLC) currently holds 11,510 shares of Abbott Laboratories (ABT) worth $1.54 M, representing 0.02% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.
Based on 13F filings since 2013, Tom Russo has maintained a long-term strategic position in ABT, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2018, adding 1,160 shares. Largest reduction occurred in Q1 2016, reducing 65,000 shares.
Analysis based on 13F filings available since 2013 Q2
Tom Russo's Abbott Laboratories (ABT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Abbott Laboratories (ABT) Trades by Tom Russo
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +86,304 | Add 0.00% | 86,303 | $34.88 |
| Q3 2013 | +200 | Add 0.23% | 86,503 | $33.19 |
| Q4 2014 | -1,103 | Reduce 1.28% | 85,400 | $45.02 |
| Q1 2016 | -65,000 | Reduce 76.11% | 20,400 | $41.81 |
| Q2 2016 | -4,000 | Reduce 19.61% | 16,400 | $39.33 |
| Q2 2017 | +200 | Add 1.22% | 16,600 | $48.61 |
| Q3 2017 | -100 | Reduce 0.60% | 16,500 | $53.33 |
| Q4 2017 | -3,700 | Reduce 22.42% | 12,800 | $57.03 |
| Q2 2018 | +1,160 | Add 9.06% | 13,960 | $60.96 |
| Q1 2019 | -1,850 | Reduce 13.25% | 12,110 | $79.93 |
| Q1 2020 | -300 | Reduce 2.48% | 11,810 | $78.92 |
| Q3 2020 | +165 | Add 1.40% | 11,975 | $108.81 |
| Q3 2021 | +300 | Add 2.51% | 12,275 | $118.13 |
| Q2 2022 | -500 | Reduce 4.07% | 11,775 | $108.62 |
| Q2 2023 | -165 | Reduce 1.40% | 11,610 | $109.02 |
| Q2 2024 | -100 | Reduce 0.86% | 11,510 | $103.91 |
Tom Russo's Abbott Laboratories Investment FAQs
Tom Russo first purchased Abbott Laboratories (ABT) in Q2 2013, acquiring 86,303 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Tom Russo has held Abbott Laboratories (ABT) for 50 quarters since Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Tom Russo's largest addition to Abbott Laboratories (ABT) was in Q2 2013, adding 86,303 shares worth $3.01 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Tom Russo's firm, Gardner Russo & Quinn LLC, owns 11,510 shares of Abbott Laboratories (ABT), valued at approximately $1.54 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Abbott Laboratories (ABT) represents approximately 0.02% of Tom Russo's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Tom Russo's peak holding in Abbott Laboratories (ABT) was 86,503 shares, as reported at the end of Q3 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.